Author | Bangert, Annette | dc.contributor.author |
Author | Haecker, Sabine | dc.contributor.author |
Author | Cristofanon, Silvia | dc.contributor.author |
Author | Debatin, Klaus-Michael | dc.contributor.author |
Author | Fulda, Simone | dc.contributor.author |
Date of accession | 2018-06-13T07:11:25Z | dc.date.accessioned |
Available in OPARU since | 2018-06-13T07:11:25Z | dc.date.available |
Date of first publication | 2011 | dc.date.issued |
Language | en | dc.language.iso |
Publisher | Universität Ulm | dc.publisher |
Keyword | apoptosis | dc.subject |
Keyword | chemotherapy | dc.subject |
Keyword | glioblastoma | dc.subject |
Keyword | histone deacetylase inhibitor | dc.subject |
Keyword | drug-induced apoptosis | dc.subject |
Keyword | malignant glioma | dc.subject |
Keyword | hdac inhibitors | dc.subject |
Keyword | cancer | dc.subject |
Keyword | temozolomide | dc.subject |
Keyword | potent | dc.subject |
Keyword | ms-275 | dc.subject |
Keyword | death | dc.subject |
Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
Title | Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275 | dc.title |
Resource type | Wissenschaftlicher Artikel | dc.type |
Institution | UKU. Klinik für Kinder- und Jugendmedizin | uulm.affiliationSpecific |
DCMI Type | Text | uulm.typeDCMI |
Category | Publikationsnachweise | uulm.category |
DOI (external) | 10.1097/CAD.0b013e32834631e0 | dc.identifier.doiExternal |
Source - Title of source | Anti-Cancer Drugs | source.title |
Source - Place of publication | Lippincott, Williams & Wilkins | source.publisher |
Source - Volume | 22 | source.volume |
Source - Issue | 6 | source.issue |
Source - Year | 2011 | source.year |
Source - From page | 494 | source.fromPage |
Source - To page | 499 | source.toPage |
Source - ISSN | 0959-4973 | source.identifier.issn |
Open Access | No | uulm.OA |
Community | Universitätsklinikum Ulm | uulm.community |
WoS | 000291146000003 | uulm.identifier.wos |
Bibliography | uulm | uulm.bibliographie |